NEULANDLAB.NS
Price:
$11174
Market Cap:
$143.36B
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2008-10-13
Stock Exchange
NSE
Ticker
NEULANDLAB.NS
According to Neuland Laboratories Limited’s latest financial reports and current stock price. The company's current PE Ratio is 55.03. This represents a change of 0.36% compared to the average of 54.83 of the last 4 quarters.
The mean historical PE Ratio of Neuland Laboratories Limited over the last ten years is 31.35. The current 55.03 PE Ratio has changed 17.45% with respect to the historical average. Over the past ten years (40 quarters), NEULANDLAB.NS's PE Ratio was at its highest in in the June 2018 quarter at 363.86. The PE Ratio was at its lowest in in the March 2020 quarter at -9.75.
Average
31.35
Median
24.83
Minimum
14.15
Maximum
69.56
Discovering the peaks and valleys of Neuland Laboratories Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 142.16%
Maximum Annual PE Ratio = 69.56
Minimum Annual Increase = -55.54%
Minimum Annual PE Ratio = 14.15
Year | PE Ratio | Change |
---|---|---|
2024 | 26.79 | 89.26% |
2023 | 14.15 | -31.58% |
2022 | 20.69 | -37.77% |
2021 | 33.24 | 48.45% |
2020 | 22.39 | -55.54% |
2019 | 50.37 | -27.59% |
2018 | 69.56 | 95.45% |
2017 | 35.59 | 55.59% |
2016 | 22.87 | 28.30% |
2015 | 17.83 | 142.16% |
The current PE Ratio of Neuland Laboratories Limited (NEULANDLAB.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.54
5-year avg
23.45
10-year avg
31.35
Neuland Laboratories Limited’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuland Laboratories Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neuland Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Neuland Laboratories Limited's PE Ratio?
How is the PE Ratio calculated for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the highest PE Ratio for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the 3-year average PE Ratio for Neuland Laboratories Limited (NEULANDLAB.NS)?
What is the 5-year average PE Ratio for Neuland Laboratories Limited (NEULANDLAB.NS)?
How does the current PE Ratio for Neuland Laboratories Limited (NEULANDLAB.NS) compare to its historical average?